Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Goutomi Chatterjee"'
Publikováno v:
Journal of Pediatric Hematology/Oncology. 43:e230-e233
Hematopoietic stem cell transplant (HSCT) is the only curative treatment modality for Wiskott-Aldrich syndrome. Haploidentical HSCT with posttransplant cyclophosphamide (PTCy) is an upcoming option in children with nonmalignant conditions. However, o
Publikováno v:
Pediatric Hematology and Oncology. 38:278-280
To the editor, Bleeding from mucocutaneous sites can sometimes pose a diagnostic dilemma to the treating physician. It can be because of inherited or acquired disorders. Proper history, examination...
Publikováno v:
Pediatric Hematology and Oncology. 36:510-513
Portal vein thrombosis in children with essential thrombocythemia (ET) is a rarity. Here, we describe the long-term follow up of our previously reported case that since has developed portal vein thrombosis (PVT) 7-years after diagnosis. Our patient h
Publikováno v:
Pediatric Hematology Oncology Journal
Autor:
Srikanth Marda, Sirisha Rani Siddaiahgari, Poulomi Chatterjee, Rachna Keshwani, Satyendra Katewa, Gaurav Kharya, Atanu Chatterjee, Satya Prakash Yadav, Goutomi Chatterjee, Neha Rastogi, Intezar Mehdi
To the editor: Covid19 pandemic started in Dec 2019 and has affected >10 million people (1). Despite usage of personal protective equipment many healthcare workers (HCW) have been affected globally with Covid19 and some have died (2-4). We need a che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc04d22088243a86a0877e3e8b59a743
https://doi.org/10.22541/au.160269794.44564331/v1
https://doi.org/10.22541/au.160269794.44564331/v1
Publikováno v:
Journal of pediatric hematology/oncology. 42(8)
Autor:
Satya Prakash Yadav, Anil Sharma, Goutomi Chatterjee, Rohit Kapoor, Sagar Nivargi, Neha Rastogi
Publikováno v:
Journal of pediatric hematology/oncology. 43(7)
Background Haploidentical family donor is universally available and is fast emerging as an alternative donor choice for children with leukemia needing hematopoietic stem cell transplant (HSCT). Here we describe our experience of treating children wit
Autor:
Anil Sharma, Neha Rastogi, Rohit Kapoor, Goutomi Chatterjee, Sagar Nivargi, Shruti Kohli, Ruchira Misra, Satya Prakash Yadav
Publikováno v:
Pediatric Hematology Oncology Journal. 5:S50-S51
Publikováno v:
Pediatric Hematology Oncology Journal. 5:S18-S19
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S218-S219
Introduction Allogeneic stem cell transplant (SCT) is a curative option for children with thalassemia major. For non-Caucasian children lacking a matched donor success of haploidentical SCT with post-transplant cyclophosphamide (PTCy) has widened don